Combining Metagenomics, Network Pharmacology and RNA-Seq Strategies to Reveal the Therapeutic Effects and Mechanisms of Qingchang Wenzhong Decoction on Inflammatory Bowel Disease in Mice
Yali Yuan,Hairong Hu,Zhongmei Sun,Wenting Wang,Zhibin Wang,Mengyu Zheng,Yunqi Xing,Wenji Zhang,Muyuan Wang,Xinyu Lu,Yitong Li,Chengtao Liang,Zhengdao Lin,Chune Xie,Junxiang Li,Tangyou Mao
DOI: https://doi.org/10.2147/dddt.s473688
IF: 4.3188
2024-09-25
Drug Design Development and Therapy
Abstract:Yali Yuan, 1, 2, &ast Hairong Hu, 1, &ast Zhongmei Sun, 3, &ast Wenting Wang, 4 Zhibin Wang, 1 Mengyu Zheng, 5 Yunqi Xing, 1 Wenji Zhang, 1 Muyuan Wang, 1 Xinyu Lu, 1 Yitong Li, 1 Chengtao Liang, 1 Zhengdao Lin, 1 Chune Xie, 6 Junxiang Li, 1 Tangyou Mao 1 1 Dongfang Hospital, Beijing University of Chinese Medicine, Beijing, People's Republic of China; 2 Hebei North University, Zhangjiakou, Hebei, People's Republic of China; 3 Tianjin Nankai Hospital, Tianjin, People's Republic of China; 4 Beitaipingzhuang Community Health Service Center, Beijing, People's Republic of China; 5 King's College, London, UK; 6 Shenzhen Bao'an Traditional Chinese Medicine Hospital, Shenzhen, People's Republic of China &astThese authors contributed equally to this work Correspondence: Tangyou Mao; Junxiang Li, Email ; Background: Inflammatory bowel disease (IBD) is a chronic and recurrent inflammatory disease that lacks effective treatments. Qingchang Wenzhong Decoction (QCWZD) is a clinically effective herbal prescription that has been proven to attenuate intestinal inflammation in IBD. However, its molecular mechanism of action has not been clearly elucidated. Purpose: We aimed to probe the mechanism of QCWZD for the treatment of IBD. Methods: The dextran sulfate sodium (DSS)-induced mouse model of IBD was used to identify the molecular targets involved in the mechanism of action of QCWZD. Metagenomics sequencing was utilized to analyze the differences in gut microbiota and the functional consequences of these changes. Network pharmacology combined with RNA sequencing (RNA-seq) were employed to predict the molecular targets and mechanism of action of QCWZD, and were validated through in vivo experiments. Results: Our results demonstrated that QCWZD treatment alleviated intestinal inflammation and accelerated intestinal mucosal healing that involved restoration of microbial homeostasis. This hypothesis was supported by the results of bacterial metagenomics sequencing that showed attenuation of gut dysbiosis by QCWZD treatment, especially the depletion of the pathogenic bacterial genus Bacteroides , while increasing the beneficial microorganism Akkermansia muciniphila that led to altered bacterial gene functions, such as metabolic regulation. Network pharmacology and RNA-seq analyses showed that Th17 cell differentiation plays an important role in QCWZD-based treatment of IBD. This was confirmed by in vivo experiments showing a marked decrease in the percentage of CD3 + CD4 + IL-17 + (Th17) cells. Furthermore, our results also showed that the key factors associated with Th17 cell differentiation (IL-17, NF-κB, TNF-α and IL-6) in the colon were significantly reduced in QCWZD-treated colitis mice. Conclusion: QCWZD exerted beneficial effects in the treatment of IBD by modulating microbial homeostasis while inhibiting Th17 cell differentiation and its associated pathways, providing a novel and promising therapeutic strategy for the treatment of IBD. Keywords: intestinal bowel disease, Qingchang Wenzhong Decoction, microbial homeostasis, Th17 cells, mucosal immunity Graphical Inflammatory bowel disease (IBD), comprising Crohn's disease (CD) and ulcerative colitis (UC), is characterized by chronic recurrent diffuse inflammatory changes in the colorectal mucosa. 1,2 In recent decades, the incidence and prevalence of IBD have consistently increased throughout the world, becoming a global public health challenge, especially in North America and Western Europe. 3 The currently approved treatments for IBD do not produce satisfactory results due to several limitations and related side effects such as low responsiveness, opportunistic infections, and refractoriness. 4,5 Therefore, there is an urgent need to develop novel and safe therapies for IBD. Traditional Chinese Medicine (TCM), an ancient system of medicine with thousands of years of clinical practice history in China to prevent and treat diseases, focuses on the integrity of the human body and Nature. TCM has been able to produce effective and comprehensive therapeutic effects on diseases through medicinal decoctions prepared by the combination of various natural products taken from Nature. 6,7 Driven by modern technology, TCM has received extensive attention and shown many advances in treating IBD due to its multi-component, multi-targeted and multi-pathway therapeutic approach. 8–10 Qi -Abstract Truncated-
pharmacology & pharmacy,chemistry, medicinal